FN2 Earnings Intelligence
Medtronic plc ratios
Medtronic plc (MDT) Ratios (annual) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 4/29/2022 | 4/28/2023 | 4/26/2024 | 4/25/2025 | 4/24/2026 | 4/24/2027 est. | 4/24/2028 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $3,714 | $1,543 | $1,284 | $2,218 | $1,949 | - | - |
| + Debt | $5,674 | $1,952 | $3,024 | $4,806 | $3,720 | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $31,686 | $31,227 | $32,364 | $33,537 | $36,364 | $38,890.7 | $40,217 |
| % Growth | 5.2% | -1.4% | 3.6% | 3.6% | 8.4% | 6.9% | 3.4% |
| Gross Profit | $21,541 | $20,508 | $21,148 | $21,905 | $23,643 | - | - |
| % Margin | 68.0% | 65.7% | 65.3% | 65.3% | 65.0% | - | - |
| EBITDA | $8,459 | $8,182 | $7,791 | $8,816 | $9,425 | - | - |
| % Margin | 26.7% | 26.2% | 24.1% | 26.3% | 25.9% | - | - |
| Net Income | $5,039 | $3,758 | $3,676 | $4,662 | $4,801 | - | - |
| % Margin | 15.9% | 12.0% | 11.4% | 13.9% | 13.2% | - | - |
| Diluted EPS | $3.73 | $2.82 | $2.76 | $3.61 | $3.73 | $5.96 | $6.39 |
| % Growth | 40.2% | -24.4% | -2.1% | 30.8% | 3.3% | 59.7% | 7.3% |
| Operating Cash Flow | $7,346 | $6,039 | $6,787 | $7,044 | $7,330 | - | - |
| CapEx | $1,368 | $1,459 | $1,587 | $1,859 | $1,904 | - | - |
| Free Cash Flow | $5,978 | $4,580 | $5,200 | $5,185 | $5,426 | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 4/29/2022 | 4/28/2023 | 4/26/2024 | 4/25/2025 | 4/24/2026 | 4/24/2027 est. | 4/24/2028 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $31,686 | $31,227 | $32,364 | $33,537 | $36,364 | $38,890.7 | $40,217 |
| Gross Profit | $21,541 | $20,508 | $21,148 | $21,905 | $23,643 | - | - |
| EBITDA | $8,459 | $8,182 | $7,791 | $8,816 | $9,425 | - | - |
| Net Income | $5,039 | $3,758 | $3,676 | $4,662 | $4,801 | - | - |
| Diluted EPS | $3.73 | $2.82 | $2.76 | $3.61 | $3.73 | $5.96 | $6.39 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 4/29/2022 | 4/28/2023 | 4/26/2024 | 4/25/2025 | 4/24/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $3,714 | $1,543 | $1,284 | $2,218 | $1,949 |
| Short-term Debt | $3,742 | $20 | $1,092 | $2,874 | $1,788 |
| Long-term Debt | $1,932 | $1,932 | $1,932 | $1,932 | $1,932 |
| Total Debt | $5,674 | $1,952 | $3,024 | $4,806 | $3,720 |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 4/29/2022 | 4/28/2023 | 4/26/2024 | 4/25/2025 | 4/24/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | $7,346 | $6,039 | $6,787 | $7,044 | $7,330 |
| Capital Expenditure | $1,368 | $1,459 | $1,587 | $1,859 | $1,904 |
| Free Cash Flow | $5,978 | $4,580 | $5,200 | $5,185 | $5,426 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 4/29/2022 | 4/28/2023 | 4/26/2024 | 4/25/2025 | 4/24/2026 |
|---|---|---|---|---|---|
| Revenue Growth | 5.2% | -1.4% | 3.6% | 3.6% | 8.4% |
| Gross Margin | 68.0% | 65.7% | 65.3% | 65.3% | 65.0% |
| EBITDA Margin | 26.7% | 26.2% | 24.1% | 26.3% | 25.9% |
| Net Margin | 15.9% | 12.0% | 11.4% | 13.9% | 13.2% |
| FCF Margin | 18.9% | 14.7% | 16.1% | 15.5% | 14.9% |
| Diluted EPS Growth | 40.2% | -24.4% | -2.1% | 30.8% | 3.3% |